Listen Now
Topics Covered
- Overview and Definition of Diagnostic Technologies & Biomarkers, in the Context of COVID-19
- How Diagnostic Technologies & Biomarkers Shape & Improve Treatment Decisions
- Why the Molecular Portrait of Cancer is Important
- The Role of the Pathologist
- Benefits of Diagnostic Technologies, Biomarkers & Precision Medicine
- Predicting Response to Treatment
- Clinical Trials: How Research Contributes to Your Treatment Options
- Key Questions to Ask Your Health Care Team
- Guidelines for Preparing for Telehealth Appointments with Your Health Care Team
- Quality-of-Life Concerns & The Role of Social Distancing in Decreasing Your Exposure to COVID-19
- Questions for Our Panel of Experts
Our Panel of Experts

Mark G. Kris, MD
William and Joy Ruane Chair in Thoracic Oncology, Attending Physician, Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College

Al B. Benson, III, MD, FACP, FACCC, FASCO
Professor of Medicine, Associate Director for Cooperative Groups, Robert H. Lurie Comprehensive Cancer Center, Northwestern University

Sarah E. Kerr, MD
Pathologist, Hospital Pathology Associates, P.A., Divisions of Cytopathology; Gynecologic and Perinatal Pathology; and Molecular Diagnostics Lead Pathologist for Next Generation Sequencing Development and Practice; Allina Health Laboratory (A Part of Abbott Northwestern Hospital), Minneapolis, MN

Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on June 22, 2020.